Propanc Biopharma, Inc. Annual Return On Equity in % from 2013 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Propanc Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from 2013 to 2024.
  • Propanc Biopharma, Inc. Return On Equity for the quarter ending September 30, 2024 was 48.2 %, a 39.8% decline year-over-year.
  • Propanc Biopharma, Inc. annual Return On Equity for 2024 was 51.9 %, a 42.7% decline from 2023.
  • Propanc Biopharma, Inc. annual Return On Equity for 2023 was 90.6 %, a 4.46% decline from 2022.
  • Propanc Biopharma, Inc. annual Return On Equity for 2022 was 94.9 %, a 51.2% increase from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 51.9 -38.7 -42.7% Jul 1, 2023 Jun 30, 2024
2023 90.6 -4.23 -4.46% Jul 1, 2022 Jun 30, 2023
2022 94.9 +32.1 +51.2% Jul 1, 2021 Jun 30, 2022
2021 62.8 -38.7 -38.1% Jul 1, 2020 Jun 30, 2021
2020 101 -32.7 -24.4% Jul 1, 2019 Jun 30, 2020
2019 134 +31.4 +30.6% Jul 1, 2018 Jun 30, 2019
2018 103 -96.5 -48.4% Jul 1, 2017 Jun 30, 2018
2017 199 -99 -33.2% Jul 1, 2016 Jun 30, 2017
2016 298 +139 +87.1% Jul 1, 2015 Jun 30, 2016
2015 159 +90.8 +133% Jul 1, 2014 Jun 30, 2015
2014 68.5 -138 -66.8% Jul 1, 2013 Jun 30, 2014
2013 207 Jul 1, 2012 Jun 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.